Status:

TERMINATED

MGuard™ Prime Embolic Protection Stent in Patients With Acute ST Elevation Myocardial Infarction

Lead Sponsor:

InspireMD

Conditions:

ST Elevation Myocardial Infarction

Eligibility:

All Genders

18+ years

Brief Summary

Prospective, non-randomized, single arm, multicenter observational study. The objective is to evaluate the safety and efficacy of the MGuard™ Prime stent in the treatment of de novo stenotic lesions i...

Eligibility Criteria

Inclusion

  • Subject is \>18 years of age.
  • Subject is experiencing clinical symptoms consistent with ST elevation acute myocardial infarction (STEMI) of \>30 minutes and \<24 hours.
  • Based on coronary anatomy, primary PCI is indicated for the culprit lesion with anticipated use of stenting.
  • Subject agrees to all required follow-up procedures and visits and has provided informed consent where required.
  • The target lesion is a de novo lesion in a native coronary artery.
  • The reference vessel diameter (RVD) of the infarct lesion is 2.75-4.0 mm by visual assessment.

Exclusion

  • Subject undergoing cardiopulmonary resuscitation.
  • Cardiogenic shock (SBP \<80 mmHg for \>30 minutes, or requiring IV pressors or intra-aortic balloon bump (IABP) or other hemodynamic support device for hypotension).
  • Co-morbid condition(s) or others that could limit the subject's ability to participate in the trial or to comply with follow-up requirements, or impact the scientific integrity of the trial.
  • Target lesion involves a bifurcation with a side branch \>/=2.0 mm in diameter.
  • In the Investigator's opinion the lesion/vessel is unsuitable for treatment with the MGuard™ Prime Embolic Protection Stent System for any reason.

Key Trial Info

Start Date :

April 1 2014

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

September 1 2016

Estimated Enrollment :

63 Patients enrolled

Trial Details

Trial ID

NCT02292823

Start Date

April 1 2014

End Date

September 1 2016

Last Update

September 2 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Onze Lieve Vrouwe Gasthuis

Amsterdam, Netherlands

MGuard™ Prime Embolic Protection Stent in Patients With Acute ST Elevation Myocardial Infarction | DecenTrialz